openPR Logo
Press release

Global Scopolamine Market Growth, Size, Share, Industry Report and Forecast 2020-2026

04-30-2021 02:37 PM CET | Health & Medicine

Press release from: Orion Market Research

The scopolamine market is expected to grow at a CAGR of around 4.5% during the forecast period. Scopolamine is also known as Hyoscine that is majorly used to treat motion sickness & nausea and vomiting. It is an alkaloid drug that is extracted from the henbane plant. It is also used as a sedative and can be used along with the morphine to relieve pain. The drug requires a prescription and is not available as an over the counter drug.

Rise in the number of people suffering from stress and anxiety disorder is a major factor for the growth of the scopolamine drug market. Moreover, significant research in the field of Alzheimer's disease treatment is also undergoing related scopolamine which can provide a significant opportunity to the drug if some positive results outcomes witnessed in the near future.

To Request a Sample of our Report on Global Scopolamine Market: https://www.omrglobal.com/request-sample/scopolamine-market

However, misuse of the drug for the illegal activities is one of the major challenge to the market as the government may strict the regulations related to the distribution of the drug. When scopolamine is mixed in the beverage of a person, it can cause a range of acute psychoses including hallucinations, disorientation, and paranoia. As an estimate, around 50,000 cases of poisoning of scopolamine are registered every year in the US and Colombia each. Moreover, the presence of alternative globally is a restraining factor for the market. Ondansetron, Promethazine, Prochlorperazine are some of the alternative drugs available in the market for the treatment of nausea and vomiting.

(Get 15% Discount on Buying this Report)
A full Report of Global Scopolamine Market is Available at: https://www.omrglobal.com/industry-reports/scopolamine-market

Global Scopolamine Market Segmentation
By Type
• Scopolamine Butyl bromide
• Scopolamine Base
By Dosage type
• Oral
• Patches
• Injections

Regional Analysis

North America

• United States
• Canada

Europe

• UK
• Germany
• Spain
• France
• Italy
• Rest of Europe

Asia-Pacific

• India
• China
• Japan
• Rest oF APAC
Rest of The World

Company Profiles
• Alchem International Pvt. Ltd.
• Baxter International Inc.
• Boehringer Ingelheim International GmbH
• Cadila Healthcare Ltd.
• Caleb Pharmaceuticals, Inc.
• Fine Chemicals Corp.
• Guangzhou Hanfang Pharmaceutical Co., Ltd.
• Myungmoon Pharm Co. Ltd.
• Novartis AG
• Perrigo Co. plc
• Pfizer Inc.
• Phytex Australia

Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/scopolamine-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Scopolamine Market Growth, Size, Share, Industry Report and Forecast 2020-2026 here

News-ID: 2278157 • Views:

More Releases from Orion Market Research

Eggshell Membrane Market Set to Witness Significant Growth by 2033 | Eggnovations LLC (US), Park Premium Ingredients (US)
Eggshell Membrane Market Set to Witness Significant Growth by 2033 | Eggnovation …
The global Eggshell Membrane Market was valued at approximately USD 173.78 million in 2024, and is projected to reach USD 396.55 million by 2033, growing at a compound annual growth rate (CAGR) of 9.6% from 2025 to 2033. Eggshell Membrane Market Overview The Eggshell Membrane Market is experiencing significant growth, driven by increasing consumer awareness of its health benefits, particularly in joint health and skin care. This natural biopolymer, rich in proteins
Printable Solar Cells Market Set to Witness Significant Growth by 2033 | Armor Group, Dyesol Ltd (Greatcell Solar), Eight19 Ltd, Toshiba Corporation
Printable Solar Cells Market Set to Witness Significant Growth by 2033 | Armor G …
The global Printable Solar Cells Market was valued at approximately USD 1.2 billion in 2024, and is projected to reach USD 4.8 billion by 2033, exhibiting a strong compound annual growth rate (CAGR) of 16.7% from 2025 to 2033. Printable Solar Cells Market Overview The Printable Solar Cells Market is on a rapid upward trajectory, led by rising demand for flexible, lightweight, and cost-effective energy solutions. Printable photovoltaic technologies-including organic, perovskite,
Sales Enablement Software Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Sales Enablement Software Market Size Analysis, Competitive Insights, Leading Pl …
The Sales Enablement Software Market was valued at approximately USD 3.4 billion in 2024 and is projected to reach around USD 13.1 billion by 2033, growing at a compound annual growth rate (CAGR) of 14.7% from 2025 to 2033. Sales Enablement Software Market Overview The Sales Enablement Software Market is experiencing significant growth, driven by the increasing need for businesses to enhance their sales processes and improve team performance. These platforms
Feed management software Market Set to Witness Significant Growth by 2033 | Prairie Systems, Dairy Records Management Systems (DRMS)
Feed management software Market Set to Witness Significant Growth by 2033 | Prai …
The global Feed Management Software Market was estimated to be around USD 0.6 billion in 2024, and is projected to reach approximately USD 1.2 billion by 2033, growing at a compound annual growth rate (CAGR) of about 7.5% from 2025 to 2033. Feed Management Software Market Overview The Feed Management Software Market is expanding steadily as the agriculture and livestock industries shift toward digital transformation to optimize feed formulation and reduce

All 5 Releases


More Releases for Scopolamine

Scopolamine Market Increasing Demand, Growth Analysis and Future Outlook by 2031
The scopolamine market is estimated to augment at a CAGR of around 4.5% during the forecast period. Hyoscine is another name of the scopolamine which is majorly used to treat motion sickness & nausea and vomiting. Increasing the patient pool of the people suffering from stress and anxiety disorder due to motion sickness is the major factor for the market augmentation during the forecast period. Motion sickness is an uneasiness
Scopolamine Market Unveiled: Navigating Trends and Innovations in Antiemetic The …
The Scopolamine market plays a vital role in the pharmaceutical landscape, offering a therapeutic solution rooted in the medicinal properties of the tropane alkaloid derived from plants of the Solanaceae family. Scopolamine, recognized for its antimuscarinic effects, finds application in various medical contexts, most notably in the prevention of nausea and vomiting associated with motion sickness and anesthesia. As a key player in the antiemetic market, Scopolamine has garnered attention
Scopolamine Market Size, Share, Trends, Analysis and Forecast 2020-2026
The scopolamine market is estimated to augment at a CAGR of around 4.5% during the forecast period. Hyoscine is another name of the scopolamine which is majorly used to treat motion sickness & nausea and vomiting. Increasing the patient pool of the people suffering from stress and anxiety disorder due to motion sickness is the major factor for the market augmentation during the forecast period. Motion sickness is an uneasiness
Scopolamine Market Size, Share, Trends, Analysis and Forecast 2020-2026
The scopolamine market is estimated to augment at a CAGR of around 4.5% during the forecast period. Hyoscine is another name of the scopolamine which is majorly used to treat motion sickness & nausea and vomiting. Increasing the patient pool of the people suffering from stress and anxiety disorder due to motion sickness is the major factor for the market augmentation during the forecast period. Motion sickness is an uneasiness
Scopolamine Market With Four Main Geographies And Their Countries
This research study on "Scopolamine market" reports offers the comparative assessment of Scopolamine market and consist of Historical data, Significance, statistical data, size & share, Market Price & Demand, Business overview, Market Analysis By Product and Market Trends by Key Players. This Scopolamine Market is Segmented in two type on the basis of type of materials and end-users. It has global market covered in all the regions, ranging to that
Scopolamine Market CAGR, Key Players, Applications, Products and Regions
The Scopolamine market report gives CAGR value, Industry Chains, Upstream, Geography, End user, Application, Competitor analysis, SWOT Analysis, Sales, Revenue, Price, Gross Margin, Market Share, Import-Export, Trends and Forecast. The report also gives insight on entry and exit barriers of the industry. The Scopolamine market report covers major Manufactures Centroflora-cms, Fine Chemicals Corporation, Phytex Australia, Alchem International, Guangzhou Hanfang, Alkaloids Corporation, Luyin. Initially report provides information about Scopolamine Market Scenario, Development Prospect,